Chronic exposure to single-walled carbon nanotubes (SWCNT) has been reported to induce apoptosis resistance of human lung epithelial cells. As resistance to apoptosis is a foundation of neoplastic transformation and cancer development, we evaluated the apoptosis resistance characteristic of the exposed lung cells to understand the pathogenesis mechanism. Passage control and SWCNT-transformed human lung epithelial cells were treated with known inducers of apoptosis via the intrinsic (antimycin A and CDDP) or extrinsic (FasL and TNF-a) pathway and analyzed for apoptosis by DNA fragmentation, annexin-V expression, and caspase activation assays. Whole-genome microarray was performed to aid the analysis of apoptotic gene signaling network. The SWCNT-transformed cells exhibited defective death receptor pathway in association with cellular FLICE-inhibitory protein (c-FLIP) overexpression. Knockdown or chemical inhibition of c-FLIP abrogated the apoptosis resistance of SWCNT-transformed cells. Whole-genome expression signature analysis confirmed these findings. This study is the first to demonstrate carbon nanotube-induced defective death receptor pathway and the role of c-FLIP in the process.
To mimic this pathological process, we have developed a subchronic exposure model in which human lung epithelial cells, a key cellular target of CNT exposure and lung carcinogenesis, were continuously exposed to low-dose CNT in culture over a prolonged period, i.e. 6 months. Such long-term exposure resulted in malignant transformation of the cells that are tumorigenic in mice (Luanpitpong et al., 2014b; Wang et al., 2011) . The transformed cells also exhibited apoptosis-resistant phenotype to an inhibitor of DNA repair and an extrinsic pathway activator, with both responses potentially due to aberrant p53 signaling. As resistance to apoptosis is a foundation for neoplastic transformation and cancer development, we further investigated the key upstream molecular drivers and mechanisms of apoptosis resistance to expand upon and provide a better insight to CNT-induced carcinogenesis.
Apoptosis is a highly regulated process and is executed along two major pathways, the intrinsic (mitochondrial) pathway and extrinsic (death receptor) pathways (Ashkenazi and Dixit, 1998; Gupta, 2003) . Regulation of these pathways is accomplished by various apoptosis regulatory proteins, notably B-cell lymphoma-2 (Bcl-2) and inhibitor of apoptosis (IAP) proteins for the intrinsic pathway, and cytokine response modifier (Crm)-A and cellular FLICE-inhibitory protein (c-FLIP) for the extrinsic pathway. Dysregulation of these proteins has been clinically linked to tumor initiation and progression in a variety of cancers (Krueger et al., 2001; Luanpitpong et al., 2012; Quintavalle et al., 2010) . In this study, we investigated the ability of single-walled CNT (SWCNT) to induce apoptosis resistance of human lung epithelial cells and identified key intrinsic and/or extrinsic pathway regulatory proteins involved in the resistance process. We hypothesized that SWCNT-transformed cells developed resistance to apoptosis due to altered signal transduction in the intrinsic and/or extrinsic pathways. Identification of key molecular mechanisms for apoptosis resistance, a crucial first step in tumorigenesis, can assist in developing early disease markers and treatment strategies for CNT exposure-associated pathologies. We show that SWCNT-transformed cells exhibit apoptosis resistance via over-expressed c-FLIP in the extrinsic death receptor pathway. Understanding such cellular process will aid in the understanding of CNT pathogenesis and the development of safe nanomaterials for biomedical and commercial applications.
MATERIALS AND METHODS
Chemicals and reagents. Caspase-8 fluorometric substrate (IETD-AFC), caspase-9 fluorometric substrate (LEHD-AFC), caspase-8 inhibitor (z-IETD-FMK), caspase-9 inhibitor (z-LEHD-FMK), pan-caspase inhibitor (z-VAD-FMK), recombinant FasL (SuperFasLigand), tumor necrosis factor, and monoclonal antibody against FLIP (Dave-2) were obtained from Alexis Biochemicals (San Diego, CA). Cisplatin, antimycin A, and mouse anti-b-actin were obtained from Sigma-Aldrich (St Louis, MO). Hoechst 33342 was obtained from Molecular Probes, Inc. (Eugene, OR). Antibodies for caspase-8, caspase-9, poly(ADPribose) polymerase (PARP), and peroxidase-conjugated secondary antibodies were obtained from Cell Signaling Technology (Beverly, MA). Small-molecule death receptor sensitizer (4-[4-chloro-2-methylphenoxy]-N-hydroxybutanamide) (5809354) and its inactive analog (7271570) were obtained from ChemBridge (San Diego, CA).
SWCNT (CNI, Houston, TX) were produced by high-pressure CO disproportionation (HiPco) technique employing CO in a continuous-flow gas phase as the carbon feedstock and Fe(CO) 5 as the iron-containing catalyst precursor. They were purified by acid treatment to remove metal contaminates from the production process. Elemental analysis of the supplied SWCNT by nitric acid dissolution and inductively coupled plasma-atomic emission spectrometry (ICP-AES, NMAM #7300) showed that the SWCNT was 99% elemental carbon and 0.23% iron. The specific surface area as determined by Brunauer Emmett Teller method was 400-1000 m 2 /g. The length and width of individual SWCNT as measured by field emission scanning electron microscopy were 0.1-1 lm and 0.8-1.2 nm, respectively. The SWCNT were dispersed by acetone/sonication method as previously described (Wang et al., 2011) and suspended in phosphatebuffered saline with 2-3 min sonication (Sonic Vibra cell sonicator, Sonic & Material Inc., Newtown, CT) prior to use in cell exposure studies. These SWCNT were previously wellcharacterized and studied prior to in vitro, in vivo aspiration and inhalation exposures (Shvedova et al., 2008; Wang et al., 2011) .
Cell culture. Non-tumorigenic human bronchial epithelial BEAS-2B cells were obtained from American Type Culture Collection (Manassas, VA). The cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) medium supplemented with 5% of bovine fetal serum (FBS), 2 mM L-glutamine, and 100 U/ml penicillin/ streptomycin in a 5% CO 2 environment at 37 C. Subconfluent monolayers of human lung epithelial BEAS-2B cells were continuously exposed to a sub-toxic concentration (0.02 lg/cm 2 exposed surface area) of SWCNT in culture and passaged weekly for a period of 6 months as previously described (Wang et al., 2011) . This relatively low concentration was relevant to lung burdens achieved after in vivo exposure of mice to SWCNT (Shvedova et al., 2008) , and was equivalent to a human lung burden for 8 h/ day over a month at 400 lg/m 3 (high CNT level reported in a research facility) (Porter et al., 2010) or about 8 years at 10 lg/m 3 (average CNT level in U.S. facilities) (Erdely et al., 2013) . After the long-term exposure, SWCNT-treated cells exhibited malignant transformation and aggressive cancer phenotypes, namely excessive cell proliferation, anchorage-independent growth, high rate of migration and invasion, and apoptosis resistance (Wang et al., 2011) . The SWCNT-transformed cells and passage-control cells were designated as B-SWCNT and BEAS-2B cells, respectively and were used in this study to further investigate the apoptosis resistance mechanisms.
Apoptosis assay. Apoptosis was determined by Hoechst 33342 and annexin V-FITC/propidium iodide assays. After specific treatments, cells were incubated with 10 mg/ml Hoechst 33342 for 30 min at 37 C and analyzed for apoptosis by scoring the percentage of cells having intensely condensed chromatin and/or fragmented nuclei by fluorescence microscopy (Leica, Wetzlar, Germany). Apoptotic and necrotic cells were also examined by co-staining with annexin V-FITC/propidium iodide. After treatment, cells were washed three times in phosphate buffered saline (PBS) and resuspended in binding buffer (10 mM HEPES/ sodium hydroxide, pH 7.4, 140 mM sodium chloride, 2.5 mM calcium chloride). Cells were then incubated with 2.5 lg/ml of annexin V-FITC in the dark for 10 min, and washed again in PBS followed by addition of 5 lg/ml of propidium iodide. The fluorescence signal was analyzed by flow cytometry using a 488-nm for excitation beam, and 530-nm and 670-nm band-pass filter with CellQuest software (Becton Dickinson, San Jose, CA).
Caspase activity assay. Caspase activity was measured by fluorometric assay using the enzyme substrate IETD-amino-4-methyl coumarin (AMC) for caspase-8 and LEHD-AMC for caspase-9, which was specifically cleaved by the respective enzymes at the Asp residue to release the fluorescent leaving group, AMC. Cell extracts containing 20 mg of protein were incubated with 100 mM HEPES containing 10% sucrose, 10 mM dithiothreitol, 0.1% 3-[(3-cholamidiopropyl)-dimethylammonio]-1-propanesulfonate, and 50 mM caspase substrate in a total reaction volume of 0.25 ml. The reaction mixture was incubated for 60 min at 37 C, and quantified fluorometrically at the excitation and emission wavelengths of 380 nm and 460 nm, respectively, with an RF5301 PC spectrofluorometer (Shimadzu, Kyoto, Japan). Caspase activity was expressed as the ratio of fluorescence signal from treated and control samples.
Knockdown of c-FLIP in SWCNT-transformed cells. MISSION short hairpin ribonucleic acid (shRNA) lentiviral transduction particles were used to generate c-FLIP knockdown cells, according to manufacturer's instruction (Sigma-Aldrich, St Louis, MO). Briefly, subconfluent B-SWCNT cells were incubated in culture medium containing 8 mg/ml hexadimethrine bromide and infected with either short-hairpin (sh)-FLIP lentivirus (MISSION shRNA TRCN0000007229) or control lentivirus (MISSION nontarget shRNA control SHC002). After 48 h, the transfected cells were selected in medium containing 1 mg/ml puromycin and analyzed by immunoblotting with anti-FLIP antibody.
Immunoblotting. After specific treatments, cells were incubated with lysis buffer containing 2% Triton X-100, 1% sodium dodecyl sulfate (SDS), 100 mM NaCl, 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, and a Complete Mini cocktail protease inhibitors (Roche Molecular Biochemicals, Basel, Switzerland) for 30 min on ice. After insoluble debris was pelleted by centrifuged at 14 000 g for 15 min at 4 C, the supernatant was collected and determined for protein content using a bicinchoninic acid assay kit (Pierce Biotechnology, Rockford, IL). Proteins (60 mg) were resolved on 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto 0.45 mm nitrocellulose membranes (Bio-Rad). The membranes were blocked in 5% nonfat dry milk in Tris-buffered saline with Tween 20 (TBST) (25 mM Tris-HCl, pH 7.4, 125 mM NaCl, 0.1% Tween-20) for 1 h, followed by incubation with appropriate primary antibodies at 4 C overnight. Membranes were washed three times with TBST for 10 min, followed by incubation with horseradish peroxidaseconjugated secondary antibodies for 2 h at room temperature. The immune complexes were detected by chemiluminescence (Supersignal West Pico; Pierce, Rockford, IL) and quantified by imaging densitometry, using UN-SCAN-IT automated digitizing software (Silk Scientific Corp., Orem, UT).
cDNA microarray apoptotic signaling analysis. Whole-genome messenger RNA (mRNA) expression data (NCBI GEO #GSE56104) reported in our previous study (Luanpitpong et al., 2014a) was uploaded into Ingenuity Pathway Analysis to assess both intrinsic and extrinsic apoptotic signaling pathways. Core analysis was performed on differentially expressed genes (62-fold, P .05) compared with control cells to assess extrinsic and intrinsic apoptotic pathways, predicted upstream regulators of c-FLIP (CFLAR) and predicted downstream effects. Gene and pathway "enrichment" scores (P value) were ranked following Fisher exact test to determine their functional significance based on probability by chance alone, whereas Z-scores were used to determine prediction of activation or inhibition. Gene signaling networks and established canonical pathways associated with apoptotic function were plotted to identify key signaling hubs and overlaid with expression and activity prediction values.
Statistical analysis. Mean densitometry data from independent experiments were normalized to results of the control cells. The data are presented as the means 6 SD from three or more independent experiments. Statistical differences between the means were determined using one-or two-way Analysis of Variance (ANOVA) and Tukey-Kramer honest significant difference (HSD) post hoc tests at a significance level of P .05.
RESULTS

Apoptosis Resistance of SWCNT-Transformed Cells
Resistance to apoptosis is a key characteristic of cancer cells and a prerequisite for cancer development (Hanahan and Weinberg, 2011; Shivapurkar et al., 2003) . To test if the transformed B-SWCNT cells possess this property, we analyzed cell death response to SWCNT treatment at known apoptotic doses in the transformed and passage-control cells. Previously, low passage BEAS-2B cells showed significant increase in apoptosis following SWCNT exposure at !1.67 mg/cm 2 (Wang et al., 2011) , which is 85-fold above the sub-chronic (6 month) exposure dose (0.02 mg/cm 2 ). Here, cells were treated with various SWCNT concentrations (1.67 -8.34 mg/cm 2 ) for 48 h and analyzed for apoptosis and necrosis by flow cytometry using annexin V and propidium iodide staining assays. Figure 1a shows that SWCNT induced apoptosis with minimal effect on necrosis. The apoptotic effect of SWCNT was clearly evident in the control cells, but not in the transformed B-SWCNT cells (Figure 1a ). To confirm the results, the control and B-SWCNT cells were similarly treated with SWCNT and their dose-response relationship was determined by Hoechst 33342 assay, which measures DNA condensation and fragmentation, a key characteristic of apoptosis. Figure 1b shows that the transformed B-SWCNT cells were highly resistant to apoptosis induced by SWCNT, whereas the control cells were susceptible to the apoptosis induction. Together, these results demonstrate the acquired apoptosis-resistant phenotype of SWCNTtransformed cells.
Mitochondrial Pathway of Apoptosis
To unveil the apoptosis resistance mechanism, we first identified the apoptosis pathway that is involved in the resistance using functional and molecular approaches. Known inducers of apoptosis via the intrinsic (mitochondrial) pathway, e.g. antimycin A (ANA) and cisplatin (CDDP) (Cullen et al., 2007; Liu et al., 2008a; Park et al., 2002) , and the extrinsic (death receptor) pathway, e.g. tumor necrosis factor-a (TNF-a) and Fas ligand (FasL) (Lavrik et al., 2005; Wang et al., 2008a) , were used to probe the function of the two death pathways in SWCNT-transformed and control cells. Multiple extrinsic and intrinsic stimuli were used to determine whether apoptotic response was due to a specific stimuli's target (e.g. receptor) or molecular mechanism common to multiple stimuli (i.e. caspase activation). In the first set of experiments, cells were treated with the mitochondrial inducers CDDP (0-100 lM) and ANA (0-30 lM), and apoptosis was determined by Hoechst 33342 assay. Figure 2a shows that both CDDP and ANA were able to induce apoptosis in a dosedependent manner. The level of apoptosis induced by these agents was quite comparable in the transformed and control cells. Morphological analysis of the treated cells by Hoechst staining shows apoptotic cells exhibiting condensed or fragmented nuclei with intense nuclear fluorescence ( Figure 2b ). As caspase-9 serves as the apical caspase of the mitochondrial death pathway (Shi, 2002) , active (cleaved) caspase-9 was used PONGRAKHANANON ET AL. | 501
to evaluate the activation of this pathway by CDDP and ANA in the tested cell systems. Furthermore, poly(ADP-ribose) polymerase (PARP) cleavage was used to indicate apoptosis downstream of caspase activation. Figure 2c shows a dose-dependent increase in caspase-9 activation and PARP cleavage in the two cell systems, which are comparable. These results indicate the general preservation of apoptotic function of the mitochondrial pathway in SWCNT-transformed and control cells. 
Death Receptor Pathway of Apoptosis
To analyze the death receptor pathway of apoptosis, SWCNTtransformed and control cells were treated with TNF-a (0-100 ng/ml) and FasL (0-50 ng/ml), and their apoptotic responses were evaluated by Hoechst 33342 assay. Figure 3a and b show that both TNF-a and FasL were effective in inducing apoptosis in the control cells, but had minimal effect in the transformed B-SWCNT cells. Western blot analysis of caspase-8 (an apical caspase of the death receptor pathway) and PARP showed a dose-dependent increase in caspase-8 activation and PARP cleavage in the control cells, but not in the transformed cells (Figure 3c ). These results indicate defective death receptor pathway in the transformed B-SWCNT cells.
Inhibition of Caspases and Apoptosis
Caspases are central to the initiation and execution of apoptosis, and their inhibition by specific caspase inhibitors has been used to probe the specific pathways and mechanisms of apoptosis. For example, inhibition of apoptosis by pan-caspase inhibitors such as zVAD-fmk indicates caspase-dependent apoptotic process, whereas its inhibition by caspase-9 inhibitor (e.g. zLEHD-fmk) and caspase-8 inhibitor (e.g. zIETD-fmk) indicates the two main execution pathways of apoptosis. Other caspase-independent apoptosis or apoptotic-like cell death pathways that function independently of caspase activation, such as AIF translocation, can be identified using a pan-caspase inhibitor (Cregan et al., 2004; Leist and Jaattela, 2001 ). In addition, caspase activation does not always result in apoptosis (Perfettini and Kroemer, 2003) . To ascertain the role of caspases in BEAS-2B and B-SWCNT apoptosis, Figure 4a shows that apoptosis induced by CDDP and ANA was blocked by caspase-9 inhibitor zLEHD-fmk, whereas the effect of TNF-a and FasL was blocked by caspase-8 inhibitor zIETD-fmk. Treatment with pancaspase inhibitor zVAD-fmk resulted in similar blocking effect that did not differ from each specific caspase inhibitor. Such inhibitory effects were observed in both control and transformed B-SWCNT cells. This indicated that both cell types' apoptotic response relied on caspase-dependent apoptotic processes. Next, cells were treated with apoptogens in the absence/ presence of caspase 8 and 9 inhibitors to confirm chemical inhibition of caspase activation. Results displayed in Figure 4b confirmed this and mirrored the apoptotic functional response with TNF-a (100 ng/ml) or FasL (50 ng/ml) stained with Hoechst dye. c, Cells were similarly treated with TNF-a (0-50 ng/ml) or FasL (0-25 ng/ml) for 8 h, and cell lysates were prepared and analyzed for caspase-8 and PARP cleavage by Western blotting. Blots were reprobed with b-actin antibody to confirm equal loading of samples. Data are means 6 SD (n ¼ 4). *P .05 versus passage-matched control.
FIG. 4. Effects of caspase inhibitors on mitochondrial and death receptor pathways of apoptosis. a, Subconfluent monolayers of passage-control BEAS-2B and trans-
formed B-SWCNT cells were treated with cisplatin (CDDP, 50 lM) or antimycin A (ANA, 30 lM) in the presence or absence of pan-caspase inhibitor zVAD-fmk or caspase-9 inhibitor zLEHD-fmk, or with TNF-a (100 ng/ml) or FasL (50 ng/ml) in the presence or absence of zVAD-fmk or caspase-8 inhibitor zIETD-fmk. Apoptosis was determined by Hoechst 33342 assay at 12 h post-treatment. b, Cells were similarly treated the apoptogens in the presence or absence of specific caspase inhibitors, and caspase-9 and -8 activities were determined at 6 h post-treatment using fluorometric caspase substrates FAM-LEHD-fmk and FAM-LETD-fmk, respectively. Data are means 6 SD (n ¼ 4). *P < .05 versus untreated cells. # P .05 versus treated cells. § P .05 versus passage-matched control.
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in Figure 4a . These results substantiate the activation of mitochondrial death pathway by CDDP and ANA, and the death receptor pathway by TNF-a and FasL in the tested cell systems. These results also support our earlier finding on the acquired apoptosis resistance of SWCNT-transformed cells acting primarily through caspase-dependent process in the death receptor pathway.
Key Regulatory Proteins Involved in the Apoptosis Resistance of SWCNT-Transformed Cells
To further determine the protein(s) responsible for the apoptosis resistance of SWCNT-transformed cells, we analyzed several proteins known to be important in the death receptor pathway including TNF-a receptor 1 (TNFR1), Fas receptor (FasR), and c-FLIP in the transformed B-SWCNT and control cells (Ashkenazi and Dixit, 1998; Krueger et al., 2001) . Among these, only c-FLIP was found to be differentially expressed in the transformed and control cells, whereas other proteins were comparable in their expression (Figure 5a ). Only the long isoform of c-FLIP (c-FLIP L ) was detected, whereas the short isoform (c-FLIP S ) was undetectable in the tested cell systems. We also determined the expression of pro-caspase-8 ( Figure 3c ) and procaspase-9 (data not shown) and found no significant difference in the control and transformed cells. Similarly, no differences in caspase activity were observed between the two cell types (Figure 4b ). To support the role of c-FLIP in the apoptosis resistance of SWCNT-transformed cells, gene knockdown and chemical inhibition studies were conducted. First, a small-molecule inhibitor of c-FLIP, 5809354, was used (Schimmer et al., 2006) . This inhibitor was able to reverse the apoptosis resistance of B-SWCNT cells in response to TNF-a (0-100 ng/ml) and FasL (0-50 ng/ml) (Figure 5b ). Likewise, knockdown of c-FLIP by shRNA in the B-SWCNT cells (Figure 5c ) effectively inhibited the apoptosis resistance to TNF-a and FasL (Figure 5d ). These results indicate an important role of c-FLIP in the apoptosis resistance of SWCNT-transformed cells, consistent with the previous findings on c-FLIP-mediated resistance to death ligands such as FasL and TRAIL in lung cancer (Rippo et al., 2004; Wang et al., 2008b) .
Pathway Analysis Identifies c-FLIP as a Key Apoptosis Resistant Modulator in B-SWCNT Cells
Our previous whole-genome signature analysis in B-SWCNT cells revealed significant changes in cell proliferation, cell death, and cancer-associated gene signaling compared with passage control cells. Further investigation into cell death functional mechanisms identified a trend for inhibition of cell death/apoptosis of tumor cell lines (Z ¼ À1.96) and predicted inhibition of cell death in epithelial cell lines (Z ¼ À2.2) as topranked cell death mechanism ( Figure 6A ). Gene signaling network analysis for these two inhibited functions identified over-expressed MYC, cytochrome C (CYCS), XIAP, SNCA, and predicted Akt activation (Z ¼ 2.71) driving down-regulation of JUN, SMAD2, CDKN2A, BAD, SERPINE1, and GSK3B (data not shown). Next, analysis of the intrinsic apoptotic canonical pathway identified activated BCL2 and BCL-XL (apoptotic inhibitors) and over-expressed/activated CYCS, Apaf1, AIF, and EndoG (apoptotic activators) suggesting a still active intrinsic pathway ( Figure 6B ). As over-expressed c-FLIP protein was detected (Figure 5a ), we conducted downstream and upstream prediction analysis centered on c-FLIP (CFLAR) to identify upstream modulators and downstream apoptotic signaling effects in B-SWCNT cells. Simulation of FasL/TNF addition with activation of c-FLIP in the apoptotic canonical pathway resulted in inhibition of caspase 8, BID activity, and downstream caspase 3, resulting in extrinsic apoptotic pathway inhibition ( Figure 6B ). Activation of c-FLIP and over-expressed XIAP appear to act as sufficient blocks to caspase 3-mediated apoptosis.
DISCUSSION
In this study, we demonstrate for the first time that SWCNTtransformed cells exhibit preferentially apoptotic resistance to extrinsic death signals. This mechanism is associated with an up-regulation of the anti-apoptotic c-FLIP because inhibition of c-FLIP by either small molecule inhibitor or RNA interference alleviated this resistance. Apoptosis resistance is an initial step during oncogenic transformation allowing preferential expansion of aberrant cells over normal cells. The balance between cell proliferation and apoptosis determines the fate of the cells. Most cancer cells shift this balance toward increased cell proliferation and/or decreased apoptosis by developing a survival or anti-apoptotic mechanism (Hanahan and Weinberg, 2011) . Previous study has shown that chronic exposure to sub-toxic SWCNT induced malignant transformation of human lung epithelial cells along with self-tolerance to toxic doses (Wang et al., 2011) . In general, the avoidance of apoptosis caused by an inappropriate activation or inactivation of signal transduction in an attempt to counteract cell death facilitates the accumulation of aberrant cells. Other reports provided evidence that SWCNT induced genotoxicity and oxidative stress affecting those signaling molecules at the transcriptional and/or translational levels (Lindberg et al., 2009; Pacurari et al., 2008; Porter et al., 2010) , hence the alteration in apoptosis signaling pathway appeared in SWCNT-transformed cells. As a consequence, the cells that would be eliminated by functional apoptosis survive with the chromosomal defects and genetic instability. Additionally, disturbances in apoptosis could enhance these aberrant cells to have a potential for tumor initiation and progression.
In this regard, we identified the apoptosis signaling pathway that is defective in SWCNT-transformed cells. This is based on functional analysis of the intrinsic and extrinsic death pathways and associated regulatory enzymes. Caspase-8 is an upstream initiator in the death receptor pathway, whereas caspase-9 is a key execution enzyme in the mitochondrial pathway (Chen and Wang, 2002; Cho and Choi, 2002) . We used several known inducers of apoptosis as a tool to dissect the resistance mechanism. CDDP and ANA are inducers of the mitochondrial death pathway. The former is an anticancer agent whose mechanism of action is dependent on caspase-9 activation (Cullen et al., 2007; Liu et al., 2008a; Park et al., 2002) , whereas the latter induces apoptosis through the inhibition of mitochondrial electron transport chain, which results in disruption of membrane potential and subsequent activation of apoptotic signaling cascades (Han et al., 2008) . In the death receptor pathway, apoptosis is triggered by the interaction between death ligands, such as TNF-a and FasL, and their receptors, leading to the activation of caspase-8 and downstream signaling cascades (Lavrik et al., 2005; Wang et al., 2008a) . Our results show that the SWCNTtransformed cells were resistant to TNF-a and FasL as compared with control cells (Figure 3 ), but were comparably susceptible to CDDP and ANA (Figure 2 ), suggesting defective death receptor pathway of the transformed cells. As no large difference in apoptotic response was observed between each apoptogen, the resistance mechanism was not due to altered TNFR1 or FasL receptor expression ( Figure 5 ) or ligand/receptor interaction. Pretreatment of the cells with specific caspase inhibitors reversed the apoptotic effect of these inducers in BEAS-2B cells and further decreased apoptosis in B-SWCNT cells comparable with unexposed cell levels (Figure 4 ), substantiating our test results. In addition, both apoptogen-treated BEAS-2B and B-SWCNT cells exhibited decreased apoptosis (Figure 4a ) and caspase activity (Figure 4b ) in the presence of both specific and pan caspases inhibitors, indicating that caspase-dependent apoptosis was the dominant cell death signaling mechanism. Although it was reported that there is a crosstalk between the death receptor and mitochondrial pathways, i.e. through Bid cleavage (Chen and Wang, 2002; Cho and Choi, 2002) , we clearly showed that the death receptor pathway is the major pathway responsible for the apoptosis resistance of SWCNT-transformed cells (Figure 3 ).
There are several signaling molecules regulating the death receptor pathway, including death receptors, soluble death ligands, and c-FLIP (Krueger et al., 2001; Quintavalle et al., 2010; Wang et al., 2007) . Down-regulation of TNF-a and Fas receptors have been reported to contribute to the apoptosis resistance of , 2015, Vol. 143, No. 2 some cancer cells (Cascino et al., 1996; Moller et al., 1994) . In SWCNT-transformed cells, the expression of these receptors is, however, comparable with that in the control cells, but their expression of c-FLIP is substantially enhanced (Figure 5 ). c-FLIP has been reported to act as a suppressor of apoptosis induced by various death ligands (Gupta, 2003; Krueger et al., 2001; Wang et al., 2007 Wang et al., , 2008b due to its structural homology to caspase-8. Several TNF ligands, proto-oncogenes, p53, proteasome, and post-transcriptional modification regulate c-FLIP expression (Safa, 2012; Wang et al., 2008a) . c-FLIP interferes with the binding between caspase-8 and Fas-associated protein with death domain (FADD) which inhibits the death signal (Irmler et al., 1997) , and is consistent with our finding on the anti-apoptotic activity and overexpression of c-FLIP in SWCNT-transformed cells. We also demonstrated that small molecule inhibitor of c-FLIP, 5809354, was able to reverse the apoptosis resistance of SWCNT-transformed cells to the death ligands TNF-a and FasL ( Figure 5 ). In contrast, c-FLIP inhibitor alone or its inactive analog, 7271570, was ineffective in inducing such effect (data not shown). This result is supported by our gene knockdown experiments showing the elevated apoptotic activity of TNF-a and FasL in c-FLIP knockdown cells. Additionally, this result is in good agreement with a previous report showing the apoptosis resistance of malignant mesothelial cells and its reversal effect by c-FLIP knockdown (Rippo et al., 2004) .
| TOXICOLOGICAL SCIENCES
Alterations in c-FLIP expression and death receptor function are known to promote numerous cancers by resisting cell death and activating several established proliferation pathways (Safa, 2012) . Here, c-FLIP overexpression following sub-chronic SWCNT exposure suggests that long-term exposure to certain airborne particulates, including nanomaterials, may elicit development of a similar c-FLIP-mediated apoptosis resistant response. Particulate inhalation exposures, including carbon nanotubes, are known to result in NLRP3 inflammasome activation, inflammation, reactive oxygen, and nitrogen species (ROS/ NOS) generation and release of pro-inflammatory mediators (e.g. IL-1b and TNF-a) into lung lining fluid and blood (Donaldson et al., 2013; Dostert et al., 2008; Hussain et al., 2014) . Several of these inflammatory mediators are known modulators of apoptosis, including TNF-a (Drakopanagiotakis et al., 2008) . Repeated inflammasome activation, ROS/NOS generation and release of TNF-a or other cell death mediators would force neighboring cells to decide between apoptosis or survival via several adaptation mechanisms, including altered receptor expression or downstream signaling pathways to diminish the pro-cell death signal (Kundu and Surh, 2008; Landskron et al., 2014) . Interestingly, a recent report implicated c-FLIP L as a key component for proper NLRP3 inflammasome activation (Wu et al., 2014) . Continuous perturbation of these pathways coupled with genetic damage and/or genetic instability following SWCNT exposure (Sargent et al., 2012) potentially resulted in promotion of an apoptosis resistant phenotype through c-FLIP over-expression Wang et al., 2008b) , thus contributing to BEAS-2B cell transformation. Numerous studies argue that pro-survival or oxidative stress response mechanisms that protect normal cells from xenobiotic damage can serve to protect neoplastic or tumorigenic cells following transformation (Hanahan and Weinberg, 2011; Landskron et al., 2014; Zhang et al., 2012) . At present, little literature exists evaluating c-FLIP response to xenobiotic exposure. Schmidt et al. (2010) reported decreased c-FLIP expression and enhanced TNFrelated apoptosis-inducing ligand (TRAIL) sensitivity in endothelial and skin cells which suggests that c-FLIP is a sensitive mediator of the death receptor pathway. Therefore, it is not clear whether c-FLIP over-expression is a CNT-specific or generalized response to long-term particulate exposure. Further investigations should consider evaluating c-FLIP expression in response to long-term nano-or sub-micron particulate exposures to examine its specificity and potential role in promoting apoptotic resistance in exposed lung tissue.
CONCLUSIONS
Our study reported the acquisition of caspase-dependent apoptosis-resistant phenotype of human lung epithelial cells upon chronic exposure to SWCNT. The transformed cells exhibited defective death receptor pathway in association with c-FLIP overexpression. As apoptosis resistance is a foundation of neoplastic transformation, understanding the underlying mechanisms and identifying the key players may aid in the development of early biomarkers and drug targets for disease treatment and prevention. c-FLIP was shown to be functionally important to the survival of SWCNT-transformed cells in response to death ligands. As this molecule is overexpressed in most cancer cells, it may play a vital role in SWCNT-induced carcinogenesis. The knowledge gained from this study may be applicable to other similar nanomaterials and may aid in the development of safe nanomaterials. 
